J&J Issues New Debt, Files Financials

Ticker: JNJ · Form: 8-K · Filed: 2024-04-29T00:00:00.000Z

Sentiment: neutral

Topics: debt-issuance, financing, financial-statements

Related Tickers: JNJ

TL;DR

JNJ just dropped a bunch of new debt – $5.5B due 2024, $1.15B due 2028, $1.65B due 2035. Filing also includes votes and financials.

AI Summary

On April 25, 2024, Johnson & Johnson filed an 8-K report detailing the issuance of new debt securities. This includes $5.50 billion in notes due in 2024, $1.65 billion in notes due in 2035, and $1.15 billion in notes due in 2028. The company also reported on matters submitted to a vote of security holders and filed financial statements and exhibits.

Why It Matters

Johnson & Johnson's issuance of new debt indicates its ongoing financing activities and capital management strategies, which can impact its leverage and future investment capacity.

Risk Assessment

Risk Level: low — This filing is routine and primarily concerns debt issuance and standard corporate reporting, with no immediate negative implications.

Key Numbers

$5.50B — Notes Due 2024 (Part of new debt issuance)
$1.15B — Notes Due 2028 (Part of new debt issuance)
$1.65B — Notes Due 2035 (Part of new debt issuance)

Key Players & Entities

Johnson & Johnson (company) — Registrant
April 25, 2024 (date) — Date of earliest event reported
$5.50 billion (dollar_amount) — Notes due 2024
$1.15 billion (dollar_amount) — Notes due 2028
$1.65 billion (dollar_amount) — Notes due 2035

FAQ

What is the total principal amount of debt issued by Johnson & Johnson on April 25, 2024?

Johnson & Johnson issued a total of $8.30 billion in debt, comprising $5.50 billion in notes due 2024, $1.15 billion in notes due 2028, and $1.65 billion in notes due 2035.

What specific items are covered in this 8-K filing?

This 8-K filing covers amendments to articles of incorporation or bylaws, submission of matters to a vote of security holders, and the filing of financial statements and exhibits.

What is the maturity date for the $1.65 billion in notes issued?

The $1.65 billion in notes issued by Johnson & Johnson mature in 2035.

What is Johnson & Johnson's fiscal year end?

Johnson & Johnson's fiscal year ends on December 29th.

What is the Commission File Number for Johnson & Johnson?

The Commission File Number for Johnson & Johnson is 1-3215.

From the Filing

0000200406-24-000043.txt : 20240429 0000200406-24-000043.hdr.sgml : 20240429 20240429163250 ACCESSION NUMBER: 0000200406-24-000043 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240425 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240429 DATE AS OF CHANGE: 20240429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 24891540 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 jnj-20240425.htm 8-K jnj-20240425 0000200406 false --12-29 0000200406 2024-04-25 2024-04-25 0000200406 us-gaap:CommonStockMember 2024-04-25 2024-04-25 0000200406 jnj:A0.650NotesDue2024Member 2024-04-25 2024-04-25 0000200406 jnj:A5.50NotesDue2024Member 2024-04-25 2024-04-25 0000200406 jnj:A1.150NotesDue2028Member 2024-04-25 2024-04-25 0000200406 jnj:A1.650NotesDue2035Member 2024-04-25 2024-04-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934   Date of report (Date of earliest event reported):  April 25, 2024 Johnson & Johnson   (Exact name of registrant as specified in its charter)    New Jersey 1-3215 22-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey    08933   (Address of Principal Executive Offices) Registrant's telephone number, including area code ( 732) 524-0400   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  ☐             Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  ☐             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17                CFR 240.14d-2(b))  ☐             Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17                CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 0.650% Notes Due May 2024 JNJ24C New York Stock Exchange 5.50% Notes Due November 2024 JNJ24BP New York Stock Exchange 1.150% Notes Due November 2028 JNJ28 New York Stock Exchange 1.650% Notes Due May 2035 JNJ35 New York Stock Exchange     Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).     Emerging growth company   ☐   If an em